SCHEMBL7250095

SCHEMBL7250095

CCCCCCOc1c(C(=O)N2CCN(c3ccccc3Cl)CC2)ccc2c1C(S(=O)(=O)c1ccccc1)CS2(O)O

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.37
PKM P14618 1/20 0.37
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
DRD2 P14416 2/20 0.35
HTR2A P28223 2/20 0.35
HTR1A P08908 1/20 0.35
RBP4 P02753 1/20 0.35
KMT2A Q03164 2/20 0.34
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
TSHR P16473 1/20 0.34
HCRTR1 O43613 1/20 0.33
GRM5 P41594 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HTT P42858 1/20 0.33
AVPR1A P37288 1/20 0.33
KCNA5 P22460 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7132028 1.00 POLB (0.37) POLBPKMKDM4ELMNADRD2
SCHEMBL7134448 0.97 POLB (0.38) POLBPKMDRD2HTR2ARBP4
SCHEMBL7132031 0.92 DRD2 (0.37) POLBPKMKDM4ELMNADRD2
SCHEMBL7250100 0.92 DRD2 (0.37) POLBPKMKDM4ELMNADRD2
SCHEMBL7123802 0.91 KMT2A (0.40) POLBPKMLMNADRD2RBP4
SCHEMBL7134450 0.89 DRD2 (0.38) POLBPKMDRD2HTR2AHTR1A
SCHEMBL7131097 0.88 SCN9A (0.39) LMNAKMT2AMEN1TSHR
SCHEMBL7126478 0.88 SCN9A (0.39) LMNAKMT2AMEN1TSHR
SCHEMBL7134898 0.87 HTT (0.40) POLBPKMLMNAKMT2AMAPT
SCHEMBL7127472 0.85 HPGD (0.41) LMNAKMT2AMEN1TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420391-B1 PREVENTION AND/OR TREATMENT OF VARIOUS INFLAMMATORY DISEASES, SEPSIS, MULTIPLE MYELOMA, PLASMA CELL LEUKEMIA, OSTEOPOROSIS, CACHEXIA, PSORIASIS, NEPHRITIS, RENAL CELL CARCINOMA, KAPOSI'S SARCOMA, RHEUMATOID ARTHRITIS, GAMMOPATHY, CASTLEMAN'S ONO PHARMACEUTICAL CO., LTD. (JP) 2002-07-16 US claimed
EP-1067128-A1 FUSED THIOPHENE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-10 EP claimed
US-6555555-B1 Inhibitors of interleukin-6 and/or interleukin-12; for example 4,5-dimethyl-1,1-dioxidebenzo(b)thiophene; treating various inflammatory diseases, autoimmune diseases, cancer, osteoporosis ONO PHARMACEUTICAL CO., LTD. (JP) 2003-04-29 US disclosed
US-6420391-B1 PREVENTION AND/OR TREATMENT OF VARIOUS INFLAMMATORY DISEASES, SEPSIS, MULTIPLE MYELOMA, PLASMA CELL LEUKEMIA, OSTEOPOROSIS, CACHEXIA, PSORIASIS, NEPHRITIS, RENAL CELL CARCINOMA, KAPOSI'S SARCOMA, RHEUMATOID ARTHRITIS, GAMMOPATHY, CASTLEMAN'S ONO PHARMACEUTICAL CO., LTD. (JP) 2002-07-16 US disclosed
EP-1067128-A1 FUSED THIOPHENE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-10 EP disclosed